AXA Framlington Biotech R Dis

IMA Sector:

Specialist

ISIN:

GB0031007148

Fund Type:

Unit Trust

90.34p
   
  • PEP:
  • ISA:
  • CAT Std:
  • Date: 21-May-2013
  • Change: 0.30p
  • Change %: 0.33%
  • Currency: GBP
  • YTD change: 25.41p
  • YTD %: 39.12%

Holdings Breakdown

Holding Chart
Key % Net Assets
CELGENE CORP 7.1%
AMGEN INC 7.1%
ALEXION PHARMACEUTICALS INC 6.7%
VERTEX PHARMACEUTICAL 5.4%
Other 73.7%

Top 10 Holdings

Name % Net Assets
CELGENE CORP 7.1%
AMGEN INC 7.1%
ALEXION PHARMACEUTICALS INC 6.7%
VERTEX PHARMACEUTICAL 5.4%
TEVA PHARMACEUTICAL INDUSTRIES 4.9%
PHARMASSET INC 4.5%
SHIRE PLC 4.4%
ILLUMINA INC 4.2%
REGENERON PHARMACEUTICALS INC 4.0%
GILEAD SCIENCES INC 3.8%

Asset Allocation

Asset Allocation Chart
Key % Net Assets
USA83.60%
UK5.10%
Other11.30%
 

Price Info

Date 21-May-2013
Bid 87.67p
Offer 93.01p
Currency GBP
Change 0.30p
% 0.33%
YTD change 25.41p
YTD % 39.12%

Fund Facts

Fund Inception 31/12/2001
Fund Manager ANDY SMITH
TER 1.90 (31-Aug-2011)

Fund Reports

Minimum Investment
Initial £1000
Additional £100
Savings £50
Charges
Initial 5.50%
Annual Mang't 1.75%
Exit n/a

Risks

Name %
Standard deviation 0.03
Sharpe ratio -0.10

Top of Page